Novartis Cosentyx® gains positive CHMP opinion for pediatric psoriasis, reinforcing established efficacy and safety profile

    NEXT STORY
    Orion publishes Half-Year Financial Report for January-June 2020 on Friday 17 July 2020
    PREV STORY
    Helix BioPharma Corp. to divest remaining ownership of Polish subsidiary
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Sanofi to acquire Ablynx for €3.9 Billion

      Press ReleaseSource: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi to acquire Ablynx for €3.9 ...

    author_avatar
    NASDAQ Market News

    Celsion Announces FDA Clearance of the OVATION II Study for the Evaluation of GEN-1 Immunotherapy to Treat Newly Diagnosed Stage III/IV Ovarian Cancer

    GEN-1 to Enter the Clinic in Mid-2018 Following a Phase IB Trial Which Demonstrated ...

    author_avatar
    NASDAQ Market News

    Calithera Biosciences to Present at the 16th Annual Needham Health Care Conference

    SOUTH SAN FRANCISCO, Calif., March 29, 2017 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), ...

    author_avatar
    NASDAQ Market News